News

< Back

Awardee in the news: Valter Longo’s research on intermittent fasting, immunity and cancer highlighted in Men’s Health

On May 2, 2018, Men’s Health explored research by 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient Valter D. Longo, Ph.D.

Can Intermittent Fasting Actually Improve Your Health?” explores the growing body of research on the health benefits and safety of intermittent fasting.

The article highlights a 2014 study done by Dr. Longo and notes that during a four day fast, “both the mice and the cancer patients discarded old blood cells; once the fast was broken, their bodies produced shiny, new cells to take the place of discarded ones, thus effectively regenerating their immune systems.”

Based on this research, Longo’s study concluded “that prolonged periods of fasting could reduce the harsh side effects of chemotherapy for cancer patients…or even boost immunity for healthy people,” Men’s Health notes.

While intermittent fasting is generally considered safe for healthy people, Longo does not recommend that people fast more than 12 hours at a time; instead, he recommends a five-day fasting mimicking diet that includes soup, crackers, and tea.

A related article in Big Think notes Longo’s explanation of the health benefits of fasting. “Fasting, Longo argues, forces the body to use its store of fat, ketones, and glucose. It also breaks down a lot of white blood cells, forcing the body to regenerate new immune system cells.”

Read the article in Men’s Health and the article in Big Think here and here.


Dr. Valter Longo is the Edna M. Jones Professor of Gerontology and a Professor of Biological Sciences at the University of Southern California, Leonard Davis and the Director of the USC Longevity Institute.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President